(Q33245878)

24 July 2017

title

Partial prostatectomy using Nd:YAG laser for management of canine prostate carcinoma (English)

1 reference

Sebastiaan A van Nimwegen

24 July 2017

1 reference

object named as

Sebastiaan A van Nimwegen

2

0 references

author name string

Henry F L'Eplattenier

1

1 reference

24 July 2017

Frederik J van Sluijs

3

1 reference

24 July 2017

Jolle Kirpensteijn

4

1 reference

24 July 2017

publication date

1 June 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

35

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

406-411

1 reference

Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

A review of recent findings involving interleukin-2-based cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

In situ gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Cyclooxygenase-2 and prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Determination of canine prostatic volume using transabdominal ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-950X.2006.00165.X

10.1111/J.1532-950X.2006.00165.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference